Plunkett Research Online: Sol-Gel Technologies

SOL-GEL TECHNOLOGIES (SLGL:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog s.....



Sol-Gel Technologies
Ticker: SLGL
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972 89313429
Fax: 972 153523044444
Address: 7 Golda Meir Street
Weizmann Science Park
Ness Ziona, 7403650 Israel

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing

Ranks not available
Contacts Description
Alon Seri-LevyCEO/Co-Founder/Director
Gilad MamlokCFO
See More
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog s.....See More See More

Auditor: Kesselman & Kesselman C.P.A.s
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: